Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview

25901studies shown

Showing 217-228 of 25,901

Drug study icon

RecruitingNCT06540833

ITI-1284 for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Bulgaria, in Croatia, ...

Multiple locations, including Anaheim

SchizophreniaDrugOver 55 Years

Countries: United States, Bulgaria, Croatia, ...
Sponsor: Intra-Cellular Therapies, Inc.
Condition: Schizophrenia

Drug study icon

RecruitingNCT06887192

ML-007C-MA for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in Canada, ...

Multiple locations, including Phoenix

SchizophreniaDrugFrom 55 Years to 90 Years

Countries: United States, France, Canada, ...
Sponsor: MapLight Therapeutics
Condition: Schizophrenia

Drug study icon

RecruitingNCT06524830

VLS-01 Buccal Film, Compared to Placebo for treatment-resistant depression

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in Canada, ...

Multiple locations, including Tucson

DepressionDrugFrom 18 Years to 65 Years

Countries: United States, Australia, Canada, ...
Sponsor: atai Therapeutics, Inc.
Condition: Depression

Drug study icon

RecruitingNCT06929273

KarXT for manic episodes in bipolarity type I

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in France, ...

Multiple locations, including Bentonville

BipolarityDrugFrom 18 Years to 65 Years

Countries: United States, Australia, France, ...
Sponsor: Bristol-Myers Squibb
Condition: Bipolarity

Drug study icon

RecruitingNCT06585787

KarXT for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in France, in Belgium, ...

Multiple locations, including Gilbert

SchizophreniaDrugFrom 55 Years to 90 Years

Countries: United States, France, Belgium, ...
Sponsor: Karuna Therapeutics, Inc., a Bristol Myers Squibb company
Condition: Schizophrenia

Drug study icon

RecruitingNCT07191483

KYN-5356 in Adults With Cognitive Impairment Associated With Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Little Rock

SchizophreniaDrugFrom 18 Years to 55 Years

Countries: United States
Sponsor: Kynexis B.V.
Condition: Schizophrenia

Drug study icon

RecruitingNCT06947941

Safety and Efficacy of KarXT + KarX-EC for Schizophrenia

The registry lists this study as recruiting. Study locations are listed in the United States, in Australia, in Canada, ...

Multiple locations, including Gilbert

SchizophreniaDrugFrom 55 Years to 90 Years

Countries: United States, Australia, Canada, ...
Sponsor: Bristol-Myers Squibb
Condition: Schizophrenia

Drug study icon

RecruitingNCT07221877

Effect of KarXT on Urological Safety

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Little Rock

SchizophreniaDrugFrom 18 Years to 65 Years

Countries: United States
Sponsor: Bristol-Myers Squibb
Condition: Schizophrenia

Drug study icon

RecruitingNCT07610473

Effectiveness of DT-101 in depression

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Phoenix

DepressionDrugFrom 18 Years to 75 Years

Countries: United States
Sponsor: Draig Therapeutics Ltd
Condition: Depression

Drug study icon

RecruitingNCT07300969

Effectiveness of DT-101 in depression

The registry lists this study as recruiting. Study locations are listed in the United States, in the United Kingdom, in Bulgaria, ...

Multiple locations, including Bentonville

DepressionDrugFrom 18 Years to 75 Years

Countries: United States, United Kingdom, Bulgaria, ...
Sponsor: Draig Therapeutics Ltd
Condition: Depression

Drug study icon

RecruitingNCT07105111

Effectiveness of valbenazine in adults with tardive dyskinesia

The registry lists this study as recruiting. Study locations are listed in the United States.

Multiple locations, including Bryant

Schizophrenia, Depression, ...DrugOver 18 Years

Countries: United States
Sponsor: Neurocrine Biosciences
Condition: Schizophrenia, Depression, ...

Behavioral study icon

RecruitingNCT07380412

Effects of a Supplement on the Side Effects Associated With Stimulant Medications

The registry lists this study as recruiting. Study locations are listed in the United States.

In Las Vegas

ADHDBehavioralFrom 18 Years to 55 Years

Countries: United States
Sponsor: Outliers, Inc.
Condition: ADHD

Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.